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The well-being of the fetus depends on the efficiency of its circulatory system 
and the proper maternal-fetal exchange. Hemodynamic changes can occur due to 
disturbance of fetal and maternal homeostasis, malformations, pregnancy pathol-
ogy, and medications. Preterm labor directly affects maternal-fetal haemodynam-
ics, both due to uterine contractions and medications used to inhibit it. Research 
on maternal-fetal haemodynamics in preterm labor is currently focused mainly 
on the safety of the used tocolytics. In this chapter, we will discuss the basic prin-
ciples of fetal haemodynamics, ultrasound methods of maternal-fetal circulation 
assessment, and the influence of preterm labor on maternal-fetal haemodynam-
ics, with particular emphasis on medications used in threatening and progressive 
preterm labor.
Keywords: preterm labor, maternal-fetal haemodynamics, doppler
1. Introduction
During pregnancy, the maternal body undergoes significant hemodynamic 
changes to ensure normal fetal growth. On average, maternal cardiac output 
can increase up to 30%–45%, resulting mostly from the intensified metabolism, 
increased circulating blood mass, the appearance of an accessory placental circu-
latory system, and finally, a gradual increase in body weight during pregnancy. 
Although blood volume increases, the systemic blood pressure in a healthy mother 
undergoes no significant changes. This is mainly due to a decrease in total peripheral 
vascular resistance, primarily at the arteriolar level. The mammalian placenta is also 
important for the regulation of both the maternal and fetal circulations. Adequate 
uterine blood flow is critical to fetal growth and development [1]. Fetal heart under-
goes functional changes: throughout gestation, the fetal myocardium becomes more 
compliant and making ventricular filling less dependent on atrial contraction. Both 





The primary heart and vascular system appear in the middle of the third week of 
development. On about 22nd-23rd day, the heart begins its systolic action.
Oxygenated blood, rich in nutrients, flows through the umbilical vein from 
the placenta to the portal sinus. The portal sinus is a wide L-shaped vessel at the 
terminal end of the umbilical vein, connecting two main vessels termed the right 
and left intrahepatic portal veins perfusing the right and left hepatic lobes. It then 
goes into the ductus venosus. The ductus venosus originated from the portal sinus 
as the latter turned at an almost right angle into the right lobe of the liver. The 
ductus venosus is a branchless, hourglass-shaped vessel that ascends steeply in 
the direction of the diaphragm. The blood flow in the ductus venosus is regulated 
by the sphincter mechanism. The blood then flows in the inferior vena cava and 
enters the right atrium of the heart. Most of the blood from the inferior vena cava 
is directed to the secondary septum through the oval foramen to the left atrium. 
There it mixes with a relatively small amount of poorly oxygenated blood return-
ing through the pulmonary veins from the lungs. The blood from the left atrium 
flows into the left ventricle and leaves it through the ascending aorta. The arteries 
that supply the heart, head, neck and upper limbs receive well-oxygenated blood. 
The small amount of well-oxygenated blood from the inferior vena cava that 
remains in the right atrium of the heart mixes with the poorly oxygenated blood 
from the superior vena cava and coronary sinus and flows into the right ventricle. 
This blood leaves the right heart through the pulmonary trunk. Due to the high 
pulmonary vascular resistance during fetal life, blood flow through the lungs 
is low. About 10% of the blood flows to the lungs and most of it flows through 
the arterial duct to the fetal aorta. The blood returns to the placenta through the 
umbilical arteries [3, 4].
3. Vascular flow testing using Doppler ultrasonography
Doppler examination assessing the vascular flow of the maternal-fetal circulation 
is an important diagnostic tool in the assessment of the well-being of the fetus. The 
analysis of vascular flows is also used to make decisions about the further duration 
of pregnancy. It is often a pregnancy complicated by diseases that threaten the life of 
the mother and the fetus. Due to the high risk of iatrogenic prematurity, the experi-
ence of the person performing the ultrasound examination is extremely important, 
taking into account the factors that may affect the parameters of the vascular flow 
wave. Overinterpretation of the Doppler results may expose both parents and the 
perinatological team to unnecessary stress, medical activities and costs [5, 6].
The safety of ultrasound examinations is based on the degree of fetal expo-
sure, which depends on the amount and duration of ultrasound examinations 
and the energy used for the examination. It takes into account the control of 
the thermal and mechanical index and the superior principle of using the low-
est dose of energy that allows correct imaging - ALARA (as low as reasonably 
achievable). The term thermal index describes the quotient of the power lost to 
the reference power that increases the tissue temperature by 1 °C. The mechani-
cal index describes the amplitude of the ultrasound wave. Ensuring the safety of 
ultrasound examination is only possible through excellent knowledge of anatomy 
and embryology, as well as regular index control when changing the settings of 
the ultrasound machine.
The table contains the most frequently assessed vascular flows along with their 
correct imaging.
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The special structure of the fetal uteroplacental, umbilical and cerebral circula-
tion ensures a constant vascular flow in the fetus, independent of the mother’s heart 
cycle. This system gradually develops in the utero-fetal circulation. The significant 
effect of this phenomenon consists not only in the gradual increase in the end-dia-
stolic velocity of the flow wave, but also in the accompanying decrease in pulsation, 
which is the difference between the components of the maximum systolic and 
end-diastolic velocity.
The correct shape of the flow wave of both the fetal middle cerebral artery and 
the umbilical cord artery is not characterized by the disappearance of the flow wave 
or its inversion. It is one of the disparities in the fetal circulatory system that does 
not give a compensatory break in the heart’s work. If it occurs, it is called absent 
flow or reverse flow. Both of these phenomena are among the alarm signals of poor 
fetal condition [7].
3.1 Mistakes in Doppler examination
Due to incomplete bone calcification, the head of a premature fetus is suscep-
tible to pressure. Excessive pressure with the transducer may indicate the disappear-
ance of the end-diastolic wave in the assessed fetal middle cerebral artery [7, 8].
The assessment of the vascular flow spectrum should cover several fetal heart-
beat cycles. One of the reasons for doing this are the breathing movements of the 
fetus, which can disrupt the normal flow spectrum. Similar phenomena can be 
observed when a pregnant woman breathes too deeply. In order to verify the cor-
rectness of the vascular flow, a patient should be asked to shorten her breath or even 
temporarily stop breathing.
Incorrect parameters of the ultrasound device settings may falsify the Doppler 
measurements.
Corticosteroids administered to the mother to stimulate the maturation of the 
fetal lungs in the event of impending preterm labor may temporarily “improve” the 
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flow waves. In that case, it is reasonable to repeat the Doppler examination approxi-
mately 48 hours after administering the medications [7, 9].
4. Medications used in the preterm labor
The use of medications should take place primarily in compliance with the 
principles of patient safety and the minimum risk of side effects. The problem of 
therapy in pregnancy is related to the limited possibility of testing the effects of the 
medication on the pregnant woman and the fetus, and often the lack of consent to 
perform such tests. Therefore, medications used in pregnancy often have limited 
indications and are administered taking into account the individual risks and ben-
efits of therapy. The pharmacological action of the medication in the fetus must take 
into account the kinetics of its transformations in the mother’s organism as well as in 
the placenta. The distribution of the medication and its metabolism in the mother’s 
body determine its availability to the fetus. Since pregnancy involves profound 
physiological and biochemical changes, the metabolism of many medications is also 
significantly altered. Data from animal studies suggest that the rate of metabolism 
of medications in the liver decreases during pregnancy and their availability to 
the fetus may be greater than expected. The transfer of the medication from the 
mother’s body to the fetus takes place from arterial blood through the intervillous 
spaces to the fetal capillaries in the villi and further through the umbilical vein.
Despite the fact that the placenta is treated as a specific protective barrier for the 
fetus, it has little ability to metabolize medications. Many medications can reach 
the fetus in the form of metabolites, often more toxic [10]. The safety of the use of 
tocolytics is still a significant perinatological problem. The duration of tocolysis 
should be short enough to allow the full effect of steroid therapy on the fetus, with 
the least negative impact on the health of the mother and child [11].
The most commonly used medications that inhibit uterine contractions are 
discussed below, with particular emphasis on their effects on the circulatory system 
of the mother and the fetus.
4.1 Calcium channel blockers – nifedipine
Nifedipine contains the formula of a short- and long-acting 1,4-dihydropyridine 
calcium channel blocker. It prevents contraction of calcium-dependent myocytes 
and their vessels by blocking the influx of calcium into smooth muscle cells. The 
second possible vasodilatory mechanism is the inhibition of pH-dependent calcium 
influx by inhibiting smooth muscle carbonic anhydrase. Nifedipine is used to treat 
high blood pressure and chronic stable angina. At therapeutic sub-toxic concentra-
tions, it has little effect on myocardium and conducting cells. Inhibition of calcium 
influx lowers smooth muscle contraction, which causes dilation of the coronary 
and systemic arteries, increased oxygen delivery to the muscle tissue, reduced total 
peripheral resistance, blood pressure and afterload.
The most common side effect of nifedipine reported by mothers is headache 
associated with a transient reduction in blood pressure after initiating therapy. The 
second common effect is tachycardia. In addition, dizziness, drowsiness, nausea, a 
sharp drop in blood pressure, slurred speech and weakness may occur. One in ten 
patients may experience palpitations and hot flushes. Severe side effects, such as 
myocardial infarction, maternal dyspnea, patient hypoxia, severe maternal hypo-
tension with intrauterine fetal death, atrial fibrillation were also observed during 
nifedipine therapy. Pulmonary edema has been reported in a group of pregnant 
patients after taking nifedipine.
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It is not recommended for use in patients with twin pregnancies due to the 
more frequent occurrence of dyspnea. It is absolutely contraindicated in the group 
of patients with heart disease, maternal hypertension and intrauterine infection. 
Dyspnea occurring in twin pregnancy is explained by a reduced blood flow and 
the degree of lung ventilation due to the higher elevated diaphragm dome [11–15]. 
Nifedipine has no effect on motor activity, heart rate and blood flow in the fetus. 
The occurrence of side effects is not related to the level of this medication in the 
patient’s blood serum, so there is no need to adjust its dose based on body weight, 
body mass index (BMI) or gestational age [14].
In a study carried out on laboratory animals, the effect of nifedipine on the 
normal development of pregnancy was assessed. After administration of three and 
thirty times higher doses of nifedipine than recommended for humans, dilatation of 
blood vessels, increased vascularization of the uterus and placenta, and trophoblast 
hyperplasia were observed in both groups. Higher placental weights were seen in 
the higher dose group, but this had no effect on fetal survival or an increased risk 
of birth defects. Fetal weight did not differ from the control group at the lower 
dose, but statistically significantly lower weight was reported for the group with the 
higher dose of the drug. As expected, there were changes in the uterine muscle and 
collagen structure of the cervix during tocolysis. The authors concluded that the use 
of nifedipine in pregnancy in acceptable doses should not have a negative impact 
on the condition of fetuses and newborns, and that this therapy often improves the 
prognosis [16].
The optimal dose of nifedipine is still being determined. The starting dose in 
most studies was 10 mg either orally or sublingually. If uterine contractions were 
maintained, the dose was repeated every 15–20 minutes, until a dose of 40 mg was 
obtained in the first hour. Then, maintenance therapy is 20 mg every 6–8 hours for 
two to three days [14].
In a comparative study of nifedipine and another tocolytic combined with 
steriodotherapy, no significant risk to the fetuses was observed [17].
4.2 Beta-adrenergic receptor agonists
Ritodrine stimulates the beta-2-adrenergic receptor, increasing the level of 
cAMP and decreasing the concentration of intracellular calcium, which in turn 
leads to the relaxation of uterine smooth muscles and a reduction in the frequency 
of uterine contractions.
Terbutaline is a relatively selective bronchodilator with little or no effect on 
alpha-adrenergic receptors. It appears to have a greater effect on stimulating the 
beta receptors of the bronchi, vessels and smooth muscle, including the uterus 
(beta-2 receptors), than at the heart receptors (beta-1). This drug relaxes smooth 
muscles and inhibits uterine contractions, but it can also have a stimulating effect 
on the heart and central nervous system.
The mechanism of action is based on the stimulation of beta-adrenergic recep-
tors in intracellular adenylate cyclase, the enzyme that catalyses the conversion of 
adenosine triphosphate (ATP) to cyclic adenosine 3 ‘, 5’-monophosphate (c-AMP). 
Elevated levels of c-AMP are associated with relaxation of bronchial smooth 
muscles and inhibition of the release of immune system mediators, especially from 
mast cells.
Fenoterol stimulates beta-2 receptors in the lungs and causes bronchial smooth 
muscle relaxation, bronchodilation and increased air flow. Symptoms of overdose 
are chest pain, dizziness, dry mouth, fatigue, flu-like symptoms, headaches, heart 
abnormalities, high or low blood pressure, high blood glycemia, insomnia, muscle 
spasms, nausea, nervousness, rapid heartbeat, seizures and tremors.
Caesarean Section
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4.3 Prostaglandin synthesis inhibitors – indomethacin
As an analgesic and antipyretic drug, indomethacin inhibits the secretion of 
prostaglandins involved in the pain reaction, fever and inflammation. Symptoms 
of overdose: nausea, vomiting, severe headache, dizziness, confusion or lethargy. 
There have been reports of paraesthesia, numbness and convulsions.
4.4 Magnesium sulfate
Magnesium sulfate reduces striated muscle contraction and blocks neuromus-
cular transmission, reducing the release of acetylcholine. In addition, magnesium 
inhibits the inflow of calcium, enhancing the relaxing effect of vascular smooth 
muscles [12]. It is currently treated as a mild tocolytic. Used in fetal neuroprotection 
in preterm labor below 32 weeks of pregnancy.
4.5 Oxytocin receptor antagonist – atosiban
It is a competitive antagonist of human oxytocin at the receptor level. In 
rats and guinea pigs, atosiban has been observed to bind to oxytocin receptors, 
reducing the frequency of contractions and the tension of the uterine muscles, 
thereby reducing uterine contractions. Atosiban has also been observed to bind 
to vasopressin receptors, reducing its effect. In animals, atosiban had no effect 
on the cardiovascular system. In women at risk of preterm labor, atosiban, at the 
recommended doses, prevents uterine contractions and induces a resting state 
of the uterus. Uterine relaxation following atosiban administration is rapid, 
uterine contractions are significantly reduced within ten minutes, and uterine 
quiescence of less than four contractions per hour is achieved and stable for 
twelve hours.
In women at risk of preterm labor receiving atosiban by intravenous infusion 
(300 micrograms per minute for six to twelve hours), steady-state plasma concen-
trations were reached within one hour of starting the infusion.
The use of atosiban below 24 and above 33 weeks of pregnancy is contra-
indicated. There was no evidence of fetal toxicity. Small amounts of the drug 
are excreted into breast milk, no effect of the drug on breastfeeding has been 
acknowledged.
The most common side effects of treatment with this preparation include 
nausea, headache and dizziness, hot flushes and an increase in heart rate [18].
4.6 Medications that relax the uterine muscles
Scopolamine (hyoscine) is an alkaloid. Along with its derivatives, it resembles 
atropine and has a similar effect, but with a greater influence on the nervous 
system. Hyoscine belongs to a group of medications called parasympatholytics. The 
action of cholinolytic medications is to block the stimulation of cholinergic recep-
tors (activated by acetylcholine). Hyoscine acts on muscarinic receptors and relaxes 
smooth muscles of the gastrointestinal, biliary and urogenital tract.
Side effects may include dry mouth, atonic constipation, increased urination 
disorders, urinary retention, decreased sweat secretion, increased heart rate (tachy-
cardia), hypotension, and visual disturbances [12, 18].
Drotaverine inhibits the activity of the phosphodiesterase IV enzyme, which 
leads to an increase in the concentration of cAMP and a further cascade of intra-
cellular reactions that result in the relaxation of the muscle cell. It may also have 
calcium channel blocking abilities.
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The relaxant effect affects the smooth muscles of the gastrointestinal tract, 
urogenital system, cardiovascular system and bile ducts and is stronger than that of 
papaverine. It is used in the case of contraction of smooth muscles of both nervous 
and muscular origin. Side effects are rare and similar to scopolamine [12, 18].
5.  Effect of preterm labor and its treatment on maternal-fetal 
hemodynamics
5.1 Patient’s body position
Khatib et al. analyzed changes in vascular flow in the fetal circulation when 
changing the left lateral to supine position in pregnant women in the third trimes-
ter. Test time was approximately fifteen minutes. The authors noted a statistically 
significant decrease in the value of the pulsation index in the middle cerebral and 
umbilical artery, as well as a decrease in the maximum systolic velocity of the 
middle cerebral artery and the systolic-diastolic index of the umbilical artery [19]. 
It is most likely related to the symptom of brain sparring of the fetal circulation. As 
can be seen from the above studies, the mechanisms of circulatory centralization 
are not only activated by the pathological condition, but also by a stressful situa-
tion for the fetus, such as changing the position from a comfortable left-lateral or 
vertical position to a supine position, limiting the correct placental-fetal flow. The 
mechanism of fetal circulation centralization protects the fetus in a situation of per-
sistent limited blood flow. Vascular resistance in the cerebral circulation is reduced, 
which allows blood flow to the brain to be increased.
Katwijk and Wladimiroff analyzed changes in the value of flows in the umbilical 
artery when the body position changes. When changing the patient’s body position 
from vertical to lying, they noted an increase in the umbilical artery pulsation and 
resistance index, regardless of the gestational age, and this is explained by the flow 
mechanism of a lock [20].
Kinsella et al. in the group of twenty pregnant women in the third trimester did 
not observe any changes in the flow in the fetal umbilical artery when the patient’s 
body position was changed [21].
Similarly, Armstrong et al. in the group of twenty-five full-term pregnant 
women qualified for elective cesarean section did not observe changes in vascular 
flow depending on the different positions of the patient’s body. The authors assume 
that the degree of compression of the inferior vena cava and aorta in different 
body positions is not significant enough to disturb the vascular flow in the umbili-
cal artery, or that these changes are so subtle that Doppler devices are unable to 
capture them [22].
Marx et al. monitored the vascular flow in the umbilical cord in various body 
positions in the early stage of labor. The systolic-diastolic index of the umbilical 
artery was significantly higher in the supine position compared to the left-lateral 
position of the patient, which in turn led to an increase in vascular resistance in the 
umbilical artery [23].
Inferior vena cava syndrome most often occurs in the third trimester of preg-
nancy, when a large weight of the pregnant uterus presses on the inferior vena cava, 
especially in the supine position, which disturbs the maternal-fetal flow and may 
lead to fainting, and consequently the fetus to hypoxia. Ryo et al. undertook studies 
to determine the risk of inferior vena cava syndrome in the second trimester of 
pregnancy and its consequences for the fetus. In a group of ninety Japanese preg-
nant women between the twenty-fourth and twenty-seventh weeks of pregnancy, 
they assessed umbilical artery flow and its relationship with uteroplacental flow. 
Caesarean Section
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There were no changes in the umbilical artery resistance index during the five-
minute supine position of the patient [24].
In a study by Qu et al. on a group of fifty pregnant women between the twenty-
seventh and forty weeks of gestation, no changes in the umbilical artery flow values  
were found when the patient’s body position was changed [25], similarly to Backe et 
al. [26], while Sorensen et al. did not report changes in the systolic-diastolic index 
in patients with normal blood pressure [27].
Kinsella et al. and Witter and Besinger did not find statistically significant 
changes in uterine artery flows depending on the patient’s body position and the 
duration of the study [21, 28].
In the group between thirty-seven and forty weeks of pregnancy, Qu et al. 
observed a statistically significant increase in the resistance index in the uterine 
arteries after changing the position of the pregnant woman [25].
Sohn et al. proved that uterine flow clearly decreases in the sitting and standing 
position of the pregnant woman, which is associated with an increase in vascular 
resistance. In the conclusions, the authors emphasize that apart from uterine 
contractions, there are also other factors influencing uterine flow, which may be 
important in the monitoring of fetuses with limited growth rate [29]. In another 
work, the author presents the concept of selecting a safe position of the patient’s 
body based on the results of measurements of vascular flows in the maternal-
placental circulation [30]. Similar conclusions were presented by Easterling et al. in 
each trimester of pregnancy [31], as well as by Ryo et al. [24].
5.2 The influence of tocolytics on vascular flows
In the study by Bednarek et al. on the safety of tocolytic medications in preterm 
labor, mean values  of vascular flow measurements before the initiation of therapy 
that inhibits premature uterine contraction and at least one day after their initia-
tion, subjected to statistical analysis, did not show significant changes in most of 
the parameters studied. The changes mainly concerned the systolic-diastolic index 
in the umbilical artery, where its decrease was noted, the peak systolic velocity 
in the middle cerebral artery increased, and the pulsation index decreased. The 
patients’ therapy mainly included nifedipine. The lack of statistically significant 
changes in the value of vascular flows may indirectly confirm the safety of this 
medication and the lack of negative impact on the well-being of the mother and the 
fetus. No patients experienced life-threatening or health-threatening symptoms, 
and the reported side effects were mainly periodic headache during the first day of 
therapy and transient reddening of the skin. There was no significant decrease in 
blood pressure in patients undergoing treatment. This significantly increases the 
benefits associated with the use of this therapy, especially in relation to therapy 
with beta-mimetics, especially fenoterol.
Cornette et al. analyzed the effect of nifedipine on the values  of vascular flow in 
the cerebral and placental-fetal circulation. They found no statistically significant 
changes in the vascular flow of the fetal middle cerebral artery, umbilical cord, 
uterine arteries and ductus venous. The study was conducted in pregnant women 
between the thirty-fifth and thirty-seventh week of gestation in a group of fifteen 
healthy pregnant women, after administering 20 milligrams of nifedipine orally 
and assessing vascular flow one hour after dosing. The authors emphasize the 
mechanisms counteracting the disturbance of the uterine circulation despite the 
significant reduction of maternal afterload under the influence of nifedipine, which 
means that in healthy pregnant women with normal arterial pressure, trophoblast 
invasion lowers uterine vascular resistance to such an extent that administration of 
nifedipine, which has the ability to lower peripheral vascular resistance, is no longer 
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able to lower uterine resistance. Adverse effects of nifedipine have been reported in 
the situation of significantly lowered blood pressure in pregnant women, therefore 
it is important that the use of this medication as an inhibitor of uterine contractions 
ought to be considered only in pregnant women with normal blood pressure [32].
The study by Lima et al. was based on the administration of nifedipine in a dose 
of 20 milligrams sublingually every twenty minutes to a pregnant woman with uter-
ine contraction, until the activity subsided. Thereafter, 20 milligrams of nifedipine 
was orally administered every six hours, until a total dose of 120 milligrams per day. 
Vascular flow in the fetal and maternal circulation was assessed before the initiation 
of nifedipine, five and twenty-four hours after the initiation of the therapy. Five 
and twenty-four hours after the initiation of the therapy, there was no change in the 
resistance index from pre-treatment measurements, while a decrease in the resis-
tance index in the fetal central artery was observed between five and twenty-four 
hours after the initiation of the therapy.
The value of the peak systolic velocity of the middle cerebral artery was also 
analyzed. In the Lima study, there was a decrease after five hours, while comparing 
the measurements before and 24 hours after starting the treatment, no statistically 
significant changes were noted [33]. In the study by Bednarek et al., the peak sys-
tolic velocity of the middle cerebral artery increased statistically significantly after 
the initiation of the therapy. It is noteworthy, however, that the measurements were 
made at least twelve hours after the initiation of the therapy. Similarly, Grzesiak et 
al. reported a decrease in the peak systolic velocity in the middle cerebral artery, 
with no changes in the remaining parameters during the day after the initiation of 
oral nifedipine therapy [34].
The special structure of the fetal uteroplacental, umbilical and cerebral 
circulation ensures constant vascular flow independent of the heart cycle. This 
system gradually develops in the utero-fetal circulation. A significant effect of this 
phenomenon consists not only in the gradual increase in the velocity of the end-
diastolic flow wave, but also in the accompanying decrease in the pulsation index, 
which is the difference between the components of the maximum systolic velocity 
and the end-diastolic velocity [33].
Similarly, Guglu et al. observed a decrease in the pulse index of the central 
cerebral artery one day after the initiation of nifedipine therapy. The authors 
note that nifedipine reduces blood pressure while keeping the maternal heart rate 
unchanged. Moreover, they acknowledged a decrease in resistance in the uterine 
circulation. The mechanism of increased resistance in the umbilical artery with an 
accompanying decrease in the pulse index in the central artery of the brain prevents 
diastolic changes in the fetal heart [35, 36]. It is noteworthy that the maternal-fetal 
circulation has mechanisms that protect the fetus against changes in flow that may 
be a real threat to its well-being.
Beta-memetic therapy is now used much less frequently in suppressing preterm 
labor. Despite the lack of obvious adverse effects on vascular flow in the fetal cir-
culation, side effects in the mother are significant enough to minimize this method 
of treatment [37–39]. In a study with ritodrine, an increase in the pulse index in 
the middle artery of the fetal brain was noted, with a decrease in the pulse index 
in the umbilical artery [40]. Friedman et al. claim that therapy with ritodrine does 
not increase the resistance to placental circulation, does not lead to fetal hypoxia, 
changes in the fetal heart rate or preload on the fetal heart, but shortens the systolic 
fraction of the heart, which may lead to an increase in vascular resistance in the 
fetal circulation or reduce contractility of the heart muscle [41, 42]. Similarly, 
terbutaline increases vascular flow through the fetal heart, thus increasing its load 
[43]. Beta-agonist therapy should be limited as much as possible due to the side 
effects of these medications on both the mother and the fetus.
Caesarean Section
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Oxytocin receptor blockers are a new class of tocolytic drugs. The oxytocin 
antagonist atosiban has less side effects than beta-agonists [44]. Atosiban crosses 
the placenta. Drug concentrations in the fetal circulation do not increase with longer 
infusion rates, suggesting that the drug does not accumulate in the fetus. Atosiban has 
the best maternal and fetal safety profile; however, its costs are considerable. Maternal 
heart rate and blood flow in (R-UtA/L-UtA) were not altered significantly during 
atosiban administration. No significant changes in FHR as well as Doppler parameters 
(resistance index, pulsality index, peak systolic velocity) in umbilical artery and 
middle cerebral artery were recorded after 24/48 hours of tocolytic treatment. The 
mean values of cerebroplacental ratio (CPR) remained unaltered during treatment. 
Detailed evaluation of fetal cardiac function parameters (E/A, SF, MPI) calculated 
independently for both ventricles, revealed no significant changes over the time [45].
Tocolytic treatment with atosiban is associated with elevation of oxidative stress 
markers after a 48 hours administration. This effect of atosiban may reduce its potency 
as a tocolytic agent and therefore should be considered with respect to its clinical use, 
especially because of its connection with the occurrence of premature birth [46].
Indomethacin used as a substance inhibiting premature uterine contractile 
activity does not negatively affect the cerebral flow in the fetus, however, it should 
be remembered that long-term therapy with non-steroidal anti-inflammatory 
medications may lead to blood flow disorders in the arterial duct [47, 48].
Intravenous magnesium sulfate is also allowed in the treatment of preterm labor. 
Keeley et al. analyzed the effect of this medication on vascular flow and found a 
decrease in the flow velocity in the fetal middle cerebral artery and an increase in 
flow velocity in the uterine arteries. There were no disturbances in the flow in the 
umbilical artery. During the study, the blood circulation was normalized, which the 
authors associate with the beneficial effects of magnesium sulphate also on the fetus 
and the tocolytic effect [49]. This is also confirmed by the studies of Pezzati et al., 
who assessed the fetal and neonatal circulation in the first hours of life of children 
in the therapy of magnesium sulphate and ritodrine [50].
When analyzing the safety of tocolytic medications, it should be remembered 
that in most patients, steroid therapy is started parallel to stimulate the fetal respi-
ratory system. In the study by Bednarek et al. no significant haemodynamic changes 
were found after steroid therapy, however, other authors observed a transient 
decrease in the pulse index of the fetal middle cerebral artery [51, 52]. It cannot 
be ruled out that these differences result from the different tocolitics analyzed. 
Corticosteroids administered to the mother to stimulate the maturation of the fetal 
lungs in the event of impending preterm labor may temporarily “improve” the 
flow waves. In such a situation, it is reasonable to repeat the Doppler examination 
approximately 48 hours after administration [34].
Brar et al. reported lower efficacy of tocolysis in patients with abnormal flows 
in the maternal-fetal circulation before the therapy, which increases the risk of 
preterm labor [53].
Summing up, it should be emphasized that drugs inhibiting uterine contractions 
do not have a significant, long-term and permanent effect on the vascular flow of 
the maternal-fetal circulation. When considering the efficacy of tocolysis, other 
factors disrupting normal vascular flow should be taken into account, which may 
reduce the effectiveness of tocolytic drugs and increase the risk of preterm labor.
5.3 Preterm labor ended with cesarean section
Nakayi et al. analyzed the vascular flow of the uterine arteries on the third, 
sixth and ninth day after cesarean section. They found no significant changes in the 
resistance index in these vessels [54].
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The assessment of uterine artery flow seems to be useful in vaginal bleeding 
in puerperal patients after cesarean section, as one of the complications of this 
operation may be rupture of the intraoperatively developed pseudoaneurysm of the 
uterine artery [55].
5.4 Infection in preterm labor
Caroll et al. assessed the flow in the middle cerebral and umbilical arteries 
of fetuses and in the uterine arteries of patients with premature rupture of the 
membranes with or without intrauterine infection. They found no changes in 
vascular flow, which means that Doppler examination is not useful for monitor-
ing the developing intrauterine infection associated with premature drainage of 
amniotic fluid [56].
Different results were obtained by Yücel et al. They analyzed vascular flows 
in patients after premature drainage of amniotic fluid with histopathologically 
confirmed placental inflammation. The researchers proved that an increase in 
the systolic-diastolic index in the uterine artery can be considered as a marker of 
developing intrauterine infection [57].
5.5 Ultrasound features of the cervix shortening
Bednarek et al. observed no statistically significant changes depending on the 
length of the cervix. Similar results were established by Klemm et al. analyzing 
uterine flows after radical trachelectomy. There were no changes in the uterine 
arterial resistance index in relation to the control group [58].
The three-dimensional evaluation of the cervical circulation accounts for a new 
diagnostic possibility. Samutchaikij et al. established reference values for certain 
measurements of the cervical vascular bed, and De Diego et al. analyzed three-
dimensional images of the cervix in patients at risk of preterm labor. The authors 
found differences in the parameters of cervical vascularization in patients with 
preterm labor in comparison to asymptomatic patients with a comparable length of 
the cervix. It is possible that three-dimensional ultrasound will become a practical 
tool for the actual assessment of cervical insufficiency [59, 60].
5.6 Pregnancy duration and vascular flows
The study by Bednarek et al. involved the division of the study group into 
preterm labor below and above 32 weeks of pregnancy. Vascular flow differences 
were found in the umbilical artery. The pulsation, resistance and systolic-
diastolic index values  were higher in the younger group. Similar conclusions 
were presented by Chanprapaph et al. in the analysis of measurements in over 
three hundred healthy pregnant women. This phenomenon should be explained 
by the progressive increase in end-diastolic velocity with increasing gestational 
age, which directly translates into a decrease in the pulsation index. The authors 
draw attention to the fact that the value of the systolic-diastolic index above 
three, in a pregnancy above the thirtieth week, is more often associated with 
complications of low fetal body weight and birth disorders - the presence of 
meconium in the amniotic fluid, cesarean section and worse birth condition of 
the newborn [61–64].
Mari and Deter draw attention to the parabolic shape of the curve of changes in 
the flow rates of the central artery of the brain, the values  of which are maintained 
in newborns until the first month of life. The curves established by the authors are 




Szymon Bednarek, Małgorzata Głogiewicz, Rafał Adamczak and Mariusz Dubiel*
Department of Obstetrics and Gynecology, Nicolaus Copernicus University, 
Bydgoszcz, Poland
*Address all correspondence to: profdubiel@gmail.com
Degani found a clear decrease in the value of the middle cerebral artery pulsa-
tion index after the thirty-sixth week of pregnancy, which is related to the compen-
sation mechanism that protects the fetus against a progressive decrease in oxygen 
tension [66].
Gadelha da Costa et al. assessed the increase in fetal middle cerebral artery 
resistance index up to the twenty-sixth week of pregnancy, and then a decrease to 
the period of full-term pregnancy [67, 68].
The lack of vascular changes in the uterine arteries in pregnant women with 
pre-term labor confirms the assumption that the assessment of the flow of these 
vessels is justified in pregnancies with placental abnormalities, such as intrauterine 
growth restriction, arterial hypertension or diabetes [69, 70].
6. Summary
Research on maternal-fetal haemodynamics in preterm labor is currently 
focused mainly on the safety of the used tocolytics. The reduction of the use, and 
often the elimination of beta-agonists, undoubtedly increased the safety of the 
mother and the fetus. The above literature review proves that despite some influ-
ence of medications on maternal-fetal blood flow values, tocolysis does not signifi-
cantly disturb haemodynamics. However, it is worthwhile to remember about safety 
rules during ultrasound examinations with the use of Doppler technique.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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